Surging subscriber growth and profitability prompt ambitious long-term targets for 2030
Hims & Hers Health, Inc. (HIMS), a leading digital health and wellness platform, reported a blockbuster first quarter for 2025, with revenue soaring 111% year-over-year to $586.0 million. The company also achieved a net income of $49.5 million and Adjusted EBITDA of $91.1 million, signaling a strong start to the year and underscoring the profitability potential of its rapidly scaling business model.
Subscriber growth remained a key driver of momentum, with the platform now serving nearly 2.4 million users—up 38% from the prior year. Notably, over 1.4 million subscribers utilized personalized healthcare solutions, reflecting the company’s push to deliver tailored, consumer-centric care at scale.
“We’re starting 2025 with incredible momentum,” said CEO and co-founder Andrew Dudum. “Millions are turning to us for affordable, personalized care. As our platform evolves, we foresee deeper industry collaboration and expansion into preventative testing, diagnostics, and specialty care to reach even more people.”
CFO Yemi Okupe emphasized the company’s five-pronged growth strategy: enhancing personalization, entering new specialties, improving follow-up care access, forming innovative partnerships, and expanding geographically. “Our strong execution and consistent performance give us confidence not only in our updated 2025 outlook, but also in our ability to deliver on new long-term targets,” Okupe added.
Robust Financial Performance
- Revenue in Q1 2025 surged to $586.0 million, up from $278.2 million in Q1 2024.
- Gross margin was 73%, compared to 82% in the year-ago quarter.
- Net income rose to $49.5 million, more than quadrupling from $11.1 million.
- Adjusted EBITDA nearly tripled year-over-year, reaching $91.1 million.
- Free cash flow stood at $50.1 million, compared to $11.9 million in Q1 2024.
The results reinforce Hims & Hers’ operating leverage and financial discipline, as the company continues to scale while maintaining healthy margins.
Raised 2025 Outlook and New 2030 Targets
Following the strong Q1 results, Hims & Hers affirmed its full-year 2025 revenue guidance of $2.3 billion to $2.4 billion. The company also raised its Adjusted EBITDA outlook to a range of $295 million to $335 million, reflecting 13% to 14% margins.
In a bold move, the company introduced 2030 financial targets, aiming for at least $6.5 billion in revenue and $1.3 billion in Adjusted EBITDA—highlighting its long-term confidence in market opportunity and operational scalability.
Looking ahead to Q2 2025, the company expects revenue between $530 million and $550 million, with Adjusted EBITDA ranging from $65 million to $75 million.
With a fast-growing subscriber base, rising profitability, and a clear strategic vision, Hims & Hers is positioning itself as a dominant force in digital health for the decade ahead.
You might like this article:Amazon Delivers Strong Q1 Results but Cautions on Tariffs and Trade Pressures
